Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid symbols : AMGN save search
Global Lumakras Drug Market By Therapy Type, Disease Indication, and Region (Including COVID-19 Impact Analysis): A Report by Absolute Markets Insights
Published: 2022-03-14 (Crawled : 16:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.01%
H: 0.71%
C: 0.0%
RVMD S | $34.95 -2.46% -2.52% 1.2M
|
Health Technology
|
| O: 0.15%
H: 0.72%
C: -9.31%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 1.45%
H: 18.94%
C: 7.04%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.78%
H: 3.11%
C: -5.4%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 1.34%
H: 0.0%
C: 0.0%
covid-19 lumakras drug covid disease report therapy
mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031- Growing Beyond COVID-19 Application
Published: 2022-02-10 (Crawled : 12:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6
|
Health Technology
|
| O: -1.72%
H: 0.46%
C: -0.51%
LZAGY | $55.65 0.02% 32K
|
Professional, Scientific, and T...
|
| O: -1.31%
H: 2.63%
C: 0.75%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -2.42%
H: 0.49%
C: -2.63%
covid-19 application covid services growing
Global Wearable Injector Market: Global Forecast to 2026 With Cumulative Impact of COVID-19
Published: 2021-10-15 (Crawled : 22:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
| Email alert
Add to watchlist
WST | $372.04 -1.4% 0.0% 440K
|
Health Technology
| Email alert
Add to watchlist
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
| Email alert
Add to watchlist
covid covid-19
Outlook on the End Stage Renal Disease Global Market to 2025 - Competitive Analysis and Impact of COVID-19
Published: 2021-04-13 (Crawled : 22:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.17%
H: 0.5%
C: 0.34%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.02%
H: 1.02%
C: 0.24%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.67%
H: 0.11%
C: -0.41%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.27%
H: 0.33%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.56%
H: 0.18%
C: -0.4%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.01%
H: 0.61%
C: -0.14%
covid disease renal
BeiGene Provides Update on Phase 2 Clinical Trial of Zanubrutinib in Patients with COVID-19-Related Pulmonary Distress
Published: 2021-04-08 (Crawled : 12:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.06%
H: 0.92%
C: -3.19%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.39%
H: 0.15%
C: -0.89%
covid phase 2 trial brukinsa
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.